FDA Adverse Event Malfunction Summary report: N

UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM

MDR report key: 2211705 · Received August 5, 2011

Report

Report Number
2122870-2011-02716
Event Type
Malfunction
Date Received
August 5, 2011
Date of Event
June 14, 2008
Report Date
June 18, 2008
Manufacturer
BECKMAN COULTER, INC.
Product Code
MMI
PMA / PMN Number
K023764
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
KS, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

SERVICE WAS NOT DISPATCHED AS THE CUSTOMER DID NOT QUESTION SYSTEM PERFORMANCE. TESTING AT BECKMAN COULTER CUSTOMER PRODUCT LINE SUPPORT (CPLS) LABORATORY CONFIRMED THE EXISTENCE OF A PT SOURCE INTERFERENT FOR THE SAMPLES REC'D FROM THE CUSTOMER AS THE ROOT CAUSE FOR THE FALSELY ELEVATED RESULTS. THE SAMPLE WAS COLLECTED IN A BD LITHIUM HEPARIN TUBE WITH GEL SEPARATOR AND PROCESSED ON THE AUTOMATION LINE. PRODUCT LABELING: FOR ASSAYS EMPLOYING MOUSE ANTIBODIES, THE POSSIBILITY EXISTS FOR INTERFERENCE BY HUMAN ANTI-MOUSE ANTIBODIES (HAMA) IN THE SAMPLE. HUMAN ANTI-MOUSE ANTIBODIES MAY BE PRESENT IN SAMPLES FROM PTS WHO HAVE REC'D IMMUNOTHERAPY OR DIAGNOSIS PROCEDURES UTILIZING MONOCLONAL ANTIBODIES OR IN INDIVIDUALS WHO HAVE BEEN REGULARLY EXPOSED TO ANIMALS. ADDITIONALLY, OTHER HETEROPHILE ANTIBODIES, SUCH AS HUMAN ANTI-GOAT ANTIBODIES, MAY BE PRESENT IN PT SAMPLES. THE ACCESS ACCUTNI RESULTS SHOULD BE INTERPRETED IN LIGHT OF THE TOTAL CLINICAL PRESENTATION OF THE PT, INCLUDING: SYMPTOMS, CLINICAL HISTORY, CLINICAL EXAMINATION, ELECTROCARDIOGRAM (ECG), DATA FROM ADD'L TESTS, AND OTHER APPROPRIATE INFO. MEDICAL DECISIONS SHOULD NOT BE BASED ON A SINGLE ACCUTNI DETERMINATION AT ONE TIME POINT. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A RETROSPECTIVE REVIEW OF PRODUCT COMPLAINTS CONDUCTED FROM JANUARY 01, 2008 THROUGH OCTOBER 23, 2010 FOR ADD'L REPORTABLE EVENTS. THIS MEDWATCH REPORT IS RELATED TO MDR 2122870-2011-02741.

Description of Event or Problem · 1

THE CUSTOMER REPORTED ELEVATED TROPONIN I (ACCUTNI) RESULTS, WITHIN THE RISK STRATIFICATION RANGE, FOR ONE PT INVOLVING UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM. THIS IS REPORT NUMBER ONE OF TWO REFERENCING SYSTEM (B)(4). THE ELEVATED RESULTS WERE DISCORDANT TO AN ALTERNATE METHODOLOGY AND DID NOT CORRELATE WITH THE PT'S CLINICAL CONDITION. THE CUSTOMER NOTED THE SAMPLE WAS NOT REPEATED, AND THE ERRONEOUS RESULTS WERE RELEASED OUT OF THE LABORATORY. THERE WAS NO REPORT OF PT INJURY OR CHANGE IN PT TREATMENT ASSOCIATED WITH THIS EVENT. THE CUSTOMER SUPPLIED BECKMAN COULTER, INC. WITH THE PT SAMPLES FOR FURTHER ANALYSIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM MMI BECKMAN COULTER, INC. NA NA

Patients

Seq Age Sex Outcome Treatment
1 44 YR ACCESS ACCUTNI